Major Reforms Coming to UK Veterinary Services: What Pet Owners Need to Know
New Price Caps Aim to Protect Pet Owners from Overcharging
After conducting an extensive three-year investigation into the veterinary industry, the Competition and Markets Authority (CMA) has announced groundbreaking changes that will fundamentally transform how pet owners access and pay for veterinary care in the United Kingdom. The centerpiece of these reforms is a new price cap on pet prescriptions, which aims to address the issue of pet owners being overcharged for commonly prescribed medications. Under the new regulations, pet owners will pay a maximum of £21 for their first prescription and £12.50 for any additional medicines prescribed during the same consultation. This significant intervention comes after the CMA discovered substantial evidence that some veterinary practices were charging excessive prices for standard medications, leaving pet owners with unnecessarily high bills. The investigation revealed a concerning trend: between 2016 and 2023, the average prices of veterinary services skyrocketed by 63%, a rate that far outpaced general inflation during the same period. These findings painted a troubling picture of an industry where costs were spiraling out of control, potentially putting essential pet care out of reach for many families who consider their animals valued members of their households.
Comprehensive Transparency Measures to Empower Pet Owners
Beyond the prescription price caps, the CMA is implementing a comprehensive package of transparency measures designed to give pet owners the information they need to make informed decisions about their animals’ care. Veterinary practices will now be legally required to publish detailed price lists for standard services on their websites and in their offices. These lists must include costs for routine consultations, common procedures, diagnostic tests, written prescriptions, and even cremation options for when pets pass away. Additionally, a new comparison website will be established, allowing pet owners to easily evaluate different veterinary practices based on their pricing and services, much like how consumers currently shop for insurance or energy providers. The reforms also mandate that vets must inform customers about potential savings available by purchasing medications online using prescriptions, rather than buying directly from the practice—a practice that has previously been discouraged by some veterinary businesses. For more expensive treatments, practices will be required to provide written estimates in advance for any care expected to cost £500 or more, along with itemized bills after treatment is completed. The only exception to this requirement will be genuine emergency situations where time is of the essence. All of these changes carry the weight of law and must be implemented by September 23, ensuring compliance across the industry.
Major Veterinary Chains Under Scrutiny
The CMA investigation identified particular concerns with six large veterinary groups that dominate significant portions of the UK market: CVS, IVC, Linnaeus, Medivet, Pets at Home, and VetPartners. Martin Coleman, who chairs the independent inquiry group, didn’t mince words when addressing these major players, stating clearly that the investigation found “most of them have higher average prices than independent practices.” Even more troubling, the research demonstrated that in at least three out of five cases studied, when these large groups acquired independent practices, prices at those formerly independent clinics subsequently increased. The investigation concluded that some of these corporate groups are “earning profits significantly higher than would be expected in a well-functioning competitive market,” suggesting that market consolidation has reduced competition and allowed these businesses to charge premium prices without adequate justification. Under the new regime, these large veterinary groups will face oversight from an independent regulator for the first time, marking a significant shift in how the industry operates. The reforms also require all veterinary practices to clearly disclose their ownership structure, displaying prominently both on-site and online whether they are part of a large corporate group or operate as an independent business. This transparency is crucial because many pet owners may not realize that their local veterinary clinic, which may retain a locally-focused name, is actually owned by a large corporate chain that sets prices centrally.
Industry Response: Mixed Reactions to Reforms
The veterinary groups named in the report have responded to the CMA’s findings with varying degrees of acceptance and concern. Vets for Pets, which operates as part of the Pets at Home retail chain, acknowledged that the investigation period had been “a challenging time” for its teams but expressed satisfaction that it was the only large group whose average prices were not found to be higher than independent practices. The company emphasized its network of over 600 practice owners who are “dedicated to providing the best quality and value pet care in the communities they serve.” CVS, which operates hundreds of practices across the country, issued a carefully worded statement to investors indicating that while it believed some of the CMA reforms were not “fully justified,” it was nonetheless “comfortable with them” and considered them “workable.” The company noted it already complies with many of the new requirements and has been proactively implementing others, including publishing price lists on practice websites and implementing joint branding at numerous locations. IVC Evidensia, which boasts an impressive network of more than 2,200 clinics, hospitals, and out-of-hours facilities, offered a brief but supportive response, welcoming the report and emphasizing its commitment to “delivering outstanding care for animals and excellent support for customers.” Medivet, with its 350-plus clinics nationwide, expressed satisfaction that many of its existing practices already align with the CMA’s recommendations and specifically welcomed the finding that Medivet “does not generate excess profits,” viewing this as vindication of its pricing practices.
The Broader Context: Rising Costs and Industry Challenges
The British Veterinary Association, representing the veterinary profession broadly (and notably not among the six large groups singled out for criticism), characterized the changes as a “really positive step” toward increasing transparency while also defending the profession against accusations of simple profiteering. Dr. Rob Williams, the association’s president, provided important context about the economic pressures facing veterinary practices: “Delivering highly skilled veterinary medicine is costly, and whilst we recognise prices have risen sharply in recent years, this is due to a number of factors, including the higher costs all businesses are experiencing—and vet practices are not immune.” This perspective highlights the complex economic realities of modern veterinary medicine, where practices face rising costs for everything from staff salaries and medical equipment to medications and facility expenses. The profession has also grappled with serious workforce challenges, including veterinary surgeon shortages, mental health concerns within the profession, and the increasing complexity and expectations of modern pet care. Pet owners today often expect—and indeed their animals deserve—the same level of sophisticated diagnostic tools and treatment options available in human medicine, from advanced imaging technologies to specialized surgical procedures and ongoing management of chronic conditions. These capabilities require significant investment in equipment, training, and facilities, all of which contribute to rising costs that must ultimately be reflected in pricing.
Looking Forward: A New Era for Pet Healthcare
Martin Coleman, in summarizing the need for these sweeping reforms, painted a stark picture of the problems that have plagued the industry: “Pet owners are left in the dark about prices even when they may be incurring costs of thousands of pounds; many are paying much more for medicines than they need to; pet owners often do not know who they are buying services from; and the large businesses that control the majority of vet practices and provide critical services are not held to account by an independent regulator.” He emphasized that these systemic failures “ultimately impacts pet owners’ ability to get the care that their animals need. This must change.” The reforms represent a recognition that pets occupy a unique and cherished place in modern British society—they are family members whose wellbeing matters deeply to millions of households, yet the services essential to their health have operated in a market with insufficient transparency and oversight. These changes acknowledge that while veterinary care is indeed a business, it cannot operate like a purely commercial enterprise without regard to the emotional and financial pressures facing pet owners who love their animals and want to provide them with necessary care. By mandating transparency, capping prescription costs, and introducing regulatory oversight of large corporate players, the CMA is attempting to rebalance the market in favor of consumers while still allowing veterinary practices to operate sustainably. The coming months will reveal how effectively these measures address the identified problems and whether they successfully make veterinary care more accessible and affordable while maintaining the quality of care that pets deserve. For the millions of pet owners across the UK who have struggled with rising costs and lack of pricing information, these reforms offer hope that caring for their beloved animals may become more manageable and transparent, allowing them to make informed decisions without sacrificing their pets’ health or their household budgets.
